Original Research

Published on 18 Jan 2024

Historical evolution of cancer genomics research in Latin America: a comprehensive visual and bibliometric analysis until 2023

in Cancer Genetics and Oncogenomics

Ivan David Lozada-Martinez
Luz Miryam Lozada-Martinez
Andrés Cabarcas-Martinez
Franklin Kevin Ruiz-Gutierrez
Jose Gabriel Aristizabal Vanegas
Katherine Julieth Amorocho Lozada
Lina María López-Álvarez
Ornella Fiorillo Moreno
Elkin Navarro Quiroz

Frontiers in Genetics

doi 10.3389/fgene.2024.1327243

256 views

Editorial

Accepted on 15 Jan 2024

Editorial: Recent Advances in the Molecular Gene6cs and Precision Medicine of Lung Carcinoma

in Cancer Genetics and Oncogenomics

Mehdi Pirooznia
Xiaogang Wu
Jonathan N Bella
Fan Zhang
Dragana Jovanovic

Frontiers in Genetics

doi 10.3389/fgene.2024.1369247

Review

Accepted on 15 Jan 2024

Associations between MTHFR Gene Polymorphisms (C677T and A1298C) and Genetic Susceptibility to Prostate Cancer: A systematic review and meta-analysis

in Cancer Genetics and Oncogenomics

Jianan You
Yuhua Huang
Xinyu Shen
Yunyi Chen
Xiang Ding

Frontiers in Genetics

doi 10.3389/fgene.2024.1343687

Correction

Accepted on 15 Jan 2024

Corrigendum: A Comprehensive Analysis of HAVCR1 as a Prognostic and Diagnostic Marker for Pan-Cancer

in Cancer Genetics and Oncogenomics

Sheng Liu
Wenting Tang
Jing Cao
Mei Shang
Sun Hengchang
Jiao Gong
Bo Hu

Frontiers in Genetics

doi 10.3389/fgene.2024.1357409

Original Research

Published on 15 Jan 2024

Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy

in Cancer Genetics and Oncogenomics

Aleksandra Stanojevic
Jelena Spasic
Mladen Marinkovic
Suzana Stojanovic-Rundic
Radmila Jankovic
Ana Djuric
Jerome Zoidakis
Remond J. A. Fijneman
Sergi Castellvi-Bel
Milena Cavic

Frontiers in Genetics

doi 10.3389/fgene.2023.1299599

415 views

Mini Review

Published on 12 Jan 2024

Machine learning and multi-omics data in chronic lymphocytic leukemia: the future of precision medicine?

in Cancer Genetics and Oncogenomics

Maria Tsagiopoulou
Ivo G. Gut

Frontiers in Genetics

doi 10.3389/fgene.2023.1304661

594 views

Original Research

Accepted on 09 Jan 2024

Integrated Transcriptome and cell phenotype analysis suggest involvement of PARP1 cleavage, 2 Hippo/Wnt, TGF-β and MAPK Signaling Pathways in Ovarian Cancer Cells response to Cannabis and 3 PARP1 Inhibitor treatment 4 5

in Cancer Genetics and Oncogenomics

Nurit Shalev
Michelle Kendall
Navin Kumar
Sudeep Tiwari
Seegehalli M Anil
Hagit Hauschner
Savvemala G Swamy
Adi Doron-faigenboim
Eduard Blausov
Bruce E Kendall

Frontiers in Genetics

doi 10.3389/fgene.2024.1333964

124 views

Systematic Review

Accepted on 05 Jan 2024

Revealing the Association Between Vitamin D Metabolic Pathway Gene Variants and Lung Cancer Risk: A Systematic Review and Meta-Analysis

in Cancer Genetics and Oncogenomics

Mohamed Elsalahaty
Samar Sami Alkafaas
Aya O. Bashir
Khaled A. El-Tarabily
Mohamed T. El-Saadony
Eman Hamdy Mohamed Yousef

Frontiers in Genetics

doi 10.3389/fgene.2024.1302527

Original Research

Published on 04 Jan 2024

Dissecting cellular heterogeneity and intercellular communication in cholangiocarcinoma: implications for individualized therapeutic strategies

in Cancer Genetics and Oncogenomics

Zun-Qiang Zhou
Yi Zhang
Zi-Yang Xu
Xiao-Li Tang
Xiao-Hua Chen
Jiao Guan
Zheng-Yun Zhang

Frontiers in Genetics

doi 10.3389/fgene.2023.1241834

379 views

General Commentary

Accepted on 02 Jan 2024

Commentary "Identification of optimal reference genes for gene expression normalization in human osteosarcoma cell lines under proliferative conditions"

in Cancer Genetics and Oncogenomics

Paulo RC de-Sousa
Andreon SM da-Silva
Carlos GG Ponte
Lucas L Nogueira
Cristiane C Frota
PAULO R. Z. ANTAS

Frontiers in Genetics

doi 10.3389/fgene.2024.1342447

Original Research

Accepted on 29 Dec 2023

Liver function indicators and risk of hepatocellular carcinoma: a Bidirectional Mendelian randomization study

in Cancer Genetics and Oncogenomics

Shanshan Qin
Guoqiang Pan
Jingzhen He
Jing Wang
Shoujing Luan
Haiqing Yuan

Frontiers in Genetics

doi 10.3389/fgene.2023.1260352

Original Research

Accepted on 21 Dec 2023

Overexpression of Tousled-like kinase 2 predicts poor prognosis in HBV-related hepatocellular carcinoma patients after radical resection

in Cancer Genetics and Oncogenomics

Bang Liu
Ling-Ling Lu
Li Yu
Xuan Mei
Jia Liu
Jiao-Long Zheng
Xiao-Ling Zhou
Hai-Yan Lin
Xiu-Ling Zhu
Dong-Liang LI

Frontiers in Genetics

doi 10.3389/fgene.2023.1326737

119 views

Original Research

Published on 21 Dec 2023

Two-sample Mendelian randomization study reveals no causal relationship between inflammatory bowel disease and urological cancers

in Cancer Genetics and Oncogenomics

Haoyang Zhang
Can Hu
Zhiyu Zhang
Peng Li
Gang Shen
Jiale Sun

Frontiers in Genetics

doi 10.3389/fgene.2023.1275247

1,452 views

Original Research

Published on 18 Dec 2023

Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide

in Cancer Genetics and Oncogenomics

Tonia Carter
Robert K. Valenzuela
Srinivasulu Yerukala Sathipati
Rafael Medina-Flores

Frontiers in Genetics

doi 10.3389/fgene.2023.1320789

1,320 views

Editorial

Published on 14 Dec 2023

Editorial: Current trends and future perspectives about liquid biopsy

in Cancer Genetics and Oncogenomics

Elisa Frullanti
María José Serrano

Frontiers in Genetics

doi 10.3389/fgene.2023.1345876

670 views

Review

Published on 14 Dec 2023

Unveiling immune checkpoint regulation: exploring the power of in vivo CRISPR screenings in cancer immunotherapy

in Cancer Genetics and Oncogenomics

Yuxiang Wang
Athar Khalil
Amina Kamar
Mengyan Du
Trang Dinh
Christopher McFarland
Zhenghe Wang

Frontiers in Genetics

doi 10.3389/fgene.2023.1304425

937 views

Navigation group

Articles

Historical evolution of cancer genomics research in Latin America: a comprehensive visual and bibliometric analysis until 2023

Editorial: Recent Advances in the Molecular Gene6cs and Precision Medicine of Lung Carcinoma

Associations between MTHFR Gene Polymorphisms (C677T and A1298C) and Genetic Susceptibility to Prostate Cancer: A systematic review and meta-analysis

Corrigendum: A Comprehensive Analysis of HAVCR1 as a Prognostic and Diagnostic Marker for Pan-Cancer

Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy

Machine learning and multi-omics data in chronic lymphocytic leukemia: the future of precision medicine?

Integrated Transcriptome and cell phenotype analysis suggest involvement of PARP1 cleavage, 2 Hippo/Wnt, TGF-β and MAPK Signaling Pathways in Ovarian Cancer Cells response to Cannabis and 3 PARP1 Inhibitor treatment 4 5

Revealing the Association Between Vitamin D Metabolic Pathway Gene Variants and Lung Cancer Risk: A Systematic Review and Meta-Analysis

Dissecting cellular heterogeneity and intercellular communication in cholangiocarcinoma: implications for individualized therapeutic strategies

Commentary "Identification of optimal reference genes for gene expression normalization in human osteosarcoma cell lines under proliferative conditions"

Liver function indicators and risk of hepatocellular carcinoma: a Bidirectional Mendelian randomization study

Overexpression of Tousled-like kinase 2 predicts poor prognosis in HBV-related hepatocellular carcinoma patients after radical resection

Two-sample Mendelian randomization study reveals no causal relationship between inflammatory bowel disease and urological cancers

Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide

Editorial: Current trends and future perspectives about liquid biopsy

Unveiling immune checkpoint regulation: exploring the power of in vivo CRISPR screenings in cancer immunotherapy